A Thermodynamic Model for Genome Packaging in Hepatitis B Virus  by Kim, Jehoon & Wu, Jianzhong
Biophysical Journal Volume 109 October 2015 1689–1697 1689ArticleA Thermodynamic Model for Genome Packaging in Hepatitis B VirusJehoon Kim1 and Jianzhong Wu1,*
1Department of Chemical and Environmental Engineering, University of California at Riverside, Riverside, CaliforniaABSTRACT Understanding the fundamentals of genome packaging in viral capsids is important for finding effective antiviral
strategies and for utilizing benign viral particles for gene therapy. While the structure of encapsidated genomic materials has
been routinely characterized with experimental techniques such as cryo-electron microscopy and x-ray diffraction, much less
is known about the molecular driving forces underlying genome assembly in an intracellular environment and its in vivo interac-
tions with the capsid proteins. Here we study the thermodynamic basis of the pregenomic RNA encapsidation in human Hepatitis
B virus in vivo using a coarse-grained molecular model that captures the essential components of nonspecific intermolecular
interactions. The thermodynamic model is used to examine how the electrostatic interaction between the packaged RNA and
the highly charged C-terminal domains (CTD) of capsid proteins regulate the nucleocapsid formation. The theoretical model pre-
dicts optimal RNA content in Hepatitis B virus nucleocapsids with different CTD lengths in good agreement with mutagenesis
measurements, confirming the predominant role of electrostatic interactions and molecular excluded-volume effects in genome
packaging. We find that the amount of encapsidated RNA is not linearly correlated with the net charge of CTD tails as suggested
by earlier theoretical studies. Our thermodynamic analysis of the nucleocapsid structure and stability indicates that ~10% of the
CTD residues are free from complexation with RNA, resulting in partially exposed CTD tails. The thermodynamic model also
predicts the free energy of complex formation between macromolecules, which corroborates experimental results for the impact
of CTD truncation on the nucleocapsid stability.INTRODUCTIONHepatitis B virus (HBV) is a human pathogen that causes
severe liver diseases such as hepatocellular carcinoma
and liver cirrhosis (1,2). While >350,000,000 people
alive today are chronically infected by HBV, contempo-
rary treatments are effective mostly in the short term
and often plagued by adverse reactions such as drug
resistance (3). The lifecycle of HBV replication starts
with a single-stranded pregenomic (pg) RNA binding
with a large number of capsid proteins to form a fenes-
trated viral capsid. The encapsidated pgRNA undergoes
reverse transcription, first to a single-stranded (ss) DNA
and then a partially double-stranded DNA in a matured
capsid. It has been recognized that pgRNA encapsidation
is primarily driven by nonspecific electrostatic interac-
tions with the C-terminal domains (CTD) of the capsid
proteins (CPs). Each CP contains 183 amino-acid (aa)
residues, which can be divided into an N-terminal assem-
bly domain (140 aa), a nonpeptide linker (9 aa), and CTD
(34 aa) tails. CTD is rich in arginine residues and is
indispensable for proper pgRNA packaging and DNA
polymerization (4–6).
Previous mutagenesis studies indicate that pgRNA pack-
aging is strongly correlated with the net charge of the CTD
tails, leading to the so-called ‘‘charge balance hypothesis’’Submitted March 18, 2015, and accepted for publication August 10, 2015.
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0006-3495/15/10/1689/9(7–9). A partial truncation of the flexible, highly charged
CTD tails reduces the amount of encapsidated RNA, while
restoring arginine residues to the truncated CTD tails in-
creases the nucleic content. A positive correlation between
the length of C-terminal tail and the amount of RNA was
confirmed by cryo-electron microscopy measurements
(10). The balanced electrostatic interaction between the
positive charge from the CTD tails and the negative charge
from the encapsidated nucleic acid could play an important
role in many viral activities including capsid stability, as-
sembly, RNA encapsidation, and DNA replication (7).
The charge-balance hypothesis entails a stoichiometry-
like correlation between basic residues and their binding
partner of nucleic acids (8,9). While the experimental ap-
proaches have established near-quantitative charge-charge
relationships (7,8), there still exists a unresolved question
regarding how the electrostatic interaction between macro-
molecules is affected by solution conditions such as salt
concentration, identities of low molecular weight ions,
pH, and temperature (8,9). Besides, the charge distribu-
tion at the CTD tails may play an important role.
It is not clear whether all arginine residues at the C-termi-
nus make equal contributions to the electrostatic intera-
ction with encapsidated RNA or DNA during the HBV
lifecycle (9).
The regulative role of nonspecific electrostatic interac-
tions has been identified for many ssDNA/RNA viruses
that replicate through spontaneous molecular self-assemblyhttp://dx.doi.org/10.1016/j.bpj.2015.08.021
1690 Kim and Wu(11–19). It has been shown that that genome packaging is
intimately affiliated with electrostatic interactions between
the nucleic acids and oppositely charged, flexible domains
of the capsid proteins (20). Previous theoretical studies
suggest that viral packaging conforms a fixed charge ratio
between nucleic acids and capsid proteins (21–25). In
particular, a conserved ratio (N/Q ¼ 1.61) of the genome
size (N) to the overall charge of capsid proteins (Q) was
proposed based on observations for >30 wild-type (WT)
viruses, and the universality of a linear relation between
capsid charge and genome size has been partially justified
with a theoretical analysis (22). However, the applicability
of a fixed charge ratio to all viruses was challenged by
more recent studies (26,27). Genome packaging involves
other mechanisms such as Donnan effects (27) and spe-
cific biological interactions including the genome structure
(28,29) that may lead to nonlinearity or different charge ra-
tios in complexation between macromolecules of opposite
charges.
The universality of a fixed charge ratio between the
capsids and nucleic acids is not applicable to HBV. The
conserved N/Q value would predict the RNA size of
~4500 bases in WT HBV, much too large compared with
the size of pgRNA (3400 bases). In addition, a fixed charge
ratio is inconsistent with the aforementioned mutagenesis
studies that led to the charge-balance hypothesis (7–9). To
describe electrostatic interactions between capsid proteins
and nucleic acids, we need an improved model that takes
into account the uneven contribution of the charged residues
at the C-terminal tail as well as confinement effects due to
the partially charged capsid shell. Besides, small salt ions
play an important role in genome packaging and must be
explicitly considered. For HBV, genome packaging is also
related to the partial exposure of the CTD tails (30,31).
CTD exposure changes not only the charge balance but
also the surface properties of the viral particle important
for biological activities such as nuclear entry and export
(32,33).
Developing new therapeutic antiviral strategies for HBV
can be helped with a good understanding of the molecular
details of viral packaging. One of the critical questions
about the HBV replication is how the RNA/DNA chains
are associated with the flexible domains of the capsid
proteins leading to the nucleocapsid formation. Previously,
we studied the thermodynamic basis of RNA encapsidation
using an ion-explicit coarse-grained model for HBV cap-
sids (34). The theoretical model accounts for important
factors in regulating genome packaging including elec-
trostatic correlations, molecular excluded-volume contri-
butions, and chain connectivity effects. It predicts the
optimal size of a packaged genome in fair agreement
with existing experimental data for both WT and mutant
HBV nucleocapsids. In this study, we examine the regula-
tory role of electrostatic interactions by considering the ex-
posable feature of the CTD tails. In addition, we validateBiophysical Journal 109(8) 1689–1697the thermodynamic model with more extensive in vitro
data for partial RNA packaging in various HBV mutants
that became available only recently. Although the universal
ratio (N/Q) of the genome size to the charge of flexible
tails is not applicable to HBV (22), both theoretical and
experimental results indicate near-stoichiometric depen-
dency of the RNA size to the net charge of the CTD tails
under a specific solution condition. The discrepancies
among previous theoretical studies may be reconciled by
accounting for the molecular excluded-volume effects
and other nonspecific interactions among all viral com-
ponents including salt ions. The thermodynamic model
allows us to evaluate the free energy of the capsid forma-
tion and the radial distributions of key viral components
and subsequently, quantify the relative stability of nucleo-
capsids at different levels of CTD truncation, phosphoryla-
tion, and RNA encapsidation.MATERIALS AND METHODS
Molecular model and theory
Coarse-grained molecular model
We investigate the thermodynamic properties of HBV nucleocapsids by
representing the key viral components with a coarse-grained molecular
model. While our model does not intend to capture the atomic details or
the secondary structure of pgRNA that may play a key role in the kinetics
of viral genome encapsidation (28,35), it keeps essential ingredients of
nonspecific interactions among macromolecules underlying the thermody-
namics of nucleocapsid formation. From in vitro assembly of HBV nucle-
ocapsids in Escherichia coli, it has been noted that the RNA packaging is
insensitive to the origin of the genome or the RNA sequence (5,7). The
nonspecific nature of RNA encapsidation suggests that the essential features
of HBV capsids can be faithfully described with a coarse-grained molecular
model (34,36,37).
As in our previous work (34), the encapsidated RNA and the peptide tails
of capsid proteins are modeled as tangential chains of charged hard spheres.
Approximately, each segment corresponds to a nucleic acid or an amino-
acid residue. The diameters of hard spheres are set as sR ¼ 0.75 nm (38)
and sC ¼ 0.5 nm (39) for nucleic acids and amino-acid residues, respec-
tively. We assume that each RNA segment bears a negative unit charge.
At physiological conditions, a WT CTD tail contains 16 positively charged
segments (all from arginine residues), four negative residues (one glutamate
and three phosphorylated serine residues), and 14 neutral segments. The
valence of Z ¼ 1 or 1 is assigned for each nucleic acid (ZR) or a charged
amino-acid residue (ZC). It has been demonstrated that the coarse-grained
model is able to capture the essential features of macromolecular interac-
tions (38,40–43).
For fully flexible chains of tangentially connected hard spheres, the
bonding potential, designated as V(R), satisfies
exp
 bVRNA=CTDðRÞ ¼ Y
M1
i¼ 1
d
jriþ1  ri j  sR=C
4ps2R=C
; (1)
where b ¼ 1/(kBT), T is the absolute temperature, kB is the Boltzmann
constant, and R ¼ (r1,r2,,,,,rM) represents the configuration of a coarse-
grained RNA/CTD chain with the positions of M spherical segments spec-
ified by {ri¼1,2,,,,,M}. For a WT HBV virus, the total number of segments
is M ¼ 3400 for pgRNA, and 34 for each CTD tail. In addition to the
bonding potential, we consider the nonbonded Coulomb interactions and
unpackaged RNA 
A 
Electrostatics of Viral Replication 1691the excluded volume effects among the RNA/CTD segments using the pair-
wise additive potential uij(r),
buijðrÞ ¼
8<
:
N; r < sij;
ZiZjlB
r
; rRsij;
(2)
where sij ¼ (si þ sj)/2, and lB ¼ 0.714 nm is the Bjerrum length for an
aqueous solution at room temperature. The Coulomb and hard-sphere po-CTD 
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FIGURE 1 (A) Schematic of key components in an HBV nucleocapsid.
The optimal genome size can be determined from a partial encapsidation
of the RNA chain that minimizes the thermodynamic potential of the entire
nucleocapsid in an aqueous electrolyte solution. The unpackaged RNA
fragments are subjected to degradation by cellular nuclease. (B) The se-
quences of amino-acid residues in the CTD of the WT and mutant capsidtentials are also used to describe the interaction of macromolecules with
salt ions. In this work, the intracellular fluid is represented by an aqueous
solution of NaCl at the physiological concentration Cs ¼ 0.14 M. It has
been well documented that thermodynamic properties of the aqueous elec-
trolyte solution can be accurately reproduced with the primitive model,
assuming that the cations and the anions are charged hard spheres with di-
ameters sNaþ ¼ 0.39 nm and sCl ¼ 0.36 nm, respectively (44).
As in our previous publications (36,37), we use a spherical shell model
for the HBV T4 capsid with an inner radius RC ¼ 13 nm and a shell thick-
ness d ¼ 2 nm. The symmetric pores on the capsid shell are modeled as a
semipermeable membrane that allows transport of monomeric nucleic acids
and small ions. Because the flexible CTD tails are able to extrude outside
the capsid surface while the packaged RNA chain is fully confined, we
use an effective external potential for biomacromolecules. The confining
potential for each RNA segment is given by
fRNAðrÞ ¼

N; rRRC  0:5sR;
0; otherwise:
(3)
Each T4 HBV capsid is composed of 240 capsid proteins. Accordingly, we
assume that 240 CTD tails are randomly tethered at the inner surface of the
proteins (from residue 150 to the end). In this and other figures, the WT
and mutants of the core protein are distinguished with the number of resi-
dues (e.g., 183 179, 173, 171, and 164). The electrostatic status of each
CTD residue is labeled with different colors available on line (red, black,
and blue stand for positive (þ), neutral, and negative (), respectively).
To see this figure in color, go online.spherical shell. While the first segment of each tail is tangentially attached
at the inner capsid surface, the rest of the CTD segments are subject to an
effective external potential that allows partial exposure (~10%, the approx-
imated ratio of total pore area to inner capsid area) of the CTD chains due to
the presence of the capsid pores:
bftailðrÞ ¼

lnð0:1Þ; RC  0:5st < r <RC þ d þ 0:5st;
0; otherwise:
(4)
In addition to confinement effects, the HBV capsid exerts an electrostatic
energy on all charged components,JCi ðrÞ ¼ Zie4sðrÞ; (5)
where 4s denotes the electrostatic potential corresponding to the capsid sur-
face charge, and e represents the unit charge. For a HBV capsid, the chargedensity has been estimated to beQc¼ 0.7e/nm2, assuming a uniform charge
distribution (45). The surface charge density is used to calculate the electro-
static capsid external potential JC.
Thermodynamics of RNA encapsidation
The thermodynamics of RNA encapsidation may be considered as an equi-
librium partition of a long RNAmolecule between the inner and outer space
of the capsid. Fig. 1 depicts schematically a packaged chain at the early
stage of assembly. The exposed portion of the RNA chain is eventually
degraded by the cellular nuclease (7,46), and the inside portion defines
the optimal size of the genome.
The thermodynamic potential for the partitioning of the RNA fragments
both inside and outside the capsid can be written as
F ¼ Fcap þ Fout; (6)
where Fcap accounts for the free energy of the entire nucleocapsids, and Fout
represents the energy of the exposed RNA in the local cellular environmentoutside the capsid. At equilibrium, the optimal genome size can be found by
minimizing the overall potential
vF
vNRNA
¼ 0; (7)
where NRNA stands for the number of nucleotides of the packaged RNA
chain.We may estimate the free energy of RNA outside the capsid from the
reversible work to insert the unpackaged RNA segments into the cellular
environment. While an atomistic characterization of the cellular milieu is
not attainable, the free energy of insertion may be approximated by the
volumetric work to create a cavity in a uniform electrolyte solution with
the intracellular osmotic pressure (Pz 5 bar (47,48)),
Fout ¼ PvR

NpgRNA  NRNA

; (8)
where vR stands for the excluded volume of each nucleotide, and NpgRNA is
the number of segments of the entire pgRNA chain. Because the free energyfor the outside part of RNA is a linear function of NRNA, its derivative with
respect to NRNA, i.e., the thermodynamic potential, is independent of the
size of the unpackaged RNA. It has been shown that, under the cellular
osmotic pressure, the contribution to the total thermodynamic potential
due to the exposed RNA is relatively minor (34).
The thermodynamic potential within the nucleocapsid accounts for the
genome-capsid interactions with the participation of salt ions. The cor-
responding semigrand potential (Fcap) is estimated from the molecularBiophysical Journal 109(8) 1689–1697
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and the interaction potentials between those components and the capsid
shell,
Fcap ¼
X
a¼ 5 ions
Z
drraðrÞ½ln raðrÞ  1
þ
X
a¼ 5 ions
Z
drraðrÞ½JaðrÞ  ma
þ
X
M¼R;T
Z
dRrMðRÞJMðRÞ þ Fex;
(9)
where subscripts a andM denote salt ions and macromolecules (R ¼ RNA,
T¼ CTD tail); dR¼ dr1dr2,,,drM stands for a set of differentials; ma is the
chemical potentials of salt ions; JMðRÞ ¼
PM
i¼1JpðriÞ represents the
external potential for the polyion, while Jp(ri) is that of each segment;
Ja(r) is the external potential of small salt ions; ra(r) and rM(R) are the den-
sity profiles of small ions and polymers, respectively; and Fex is the excess
free energy due to intermolecular interactions. The excess free energy is
calculated from the classical density functional theory (DFT). We have
demonstrated in our earlier works the theoretical performance of the DFT
for inhomogeneous polyelectrolyte systems (49,50) and its successful appli-
cations to HBV nucleocapsids (34,36,37). The Supporting Material details a
self-contained description of the relevant DFT equations used in this work.RESULTS AND DISCUSSION
The optimal genome size of HBV nucleocapsid
A newly formed WT HBV nucleocapsid contains a single
copy of pgRNA, which consists of ~3400 nucleotides. It
has been shown that the HBV capsid is able to package a
similar amount of bacterial ssRNA by expression of the
full-length capsid proteins inE. coli (51).When theCTD tails
are truncated, however, the capsid contains a smaller RNA
chain. Fig. 2 shows our theoretical predictions for the pack-
aged RNA size in WT and mutant nucleocapsids with
different degrees of CTD truncation. The number of amino-
acid (aa) residues in the core protein (183 ~162) is used to
denote the WT and C-terminally truncated mutants. The162 165 168 171 174 177 180 183
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FIGURE 2 (Black open square) Theoretical predictions and experi-
mental data (Exp. 1 (7), red circle; Exp. 2 (52), blue triangle) for the optimal
RNA length (kilo-base, kb) in WT and mutant HBV nucleocapsids. To see
this figure in color, go online.
Biophysical Journal 109(8) 1689–1697theoretical data for the optimal genome size is compared
with mutagenesis studies in E. coli systems (7,52).
In general, the theoretical predictions correspond well
with those from experiments. The predicted values are
slightly higher than the experimental data probably because
our model determines the optimal genome size without
considering the polymerase and host factors, such as hsp
or hsc chaperones, kinases, and phosphatase that are
packaged in the capsid (53). Although these single-copy
proteins make little contribution to the overall charge of
the HBV capsid in comparison to the core proteins,
they occupy a certain capsid volume influencing the total
amount of packaged RNA. Nevertheless, for WT and mu-
tants with low-degree CTD truncations, the theoretical pre-
dictions are excellent. By contrast, the calculated RNA size
for mutants with a shorter CTD tail (e.g., with C-termini
residue of 162 or 164) exhibits more significant deviation
(10~20%) from the experimental data. Such a corroborated
result confirms that RNA packaging in HBV is mostly re-
gulated by nonspecific interactions between RNA and the
CTD tails.Charge balance between packaged RNA and CTD
tails
It has been speculated that, for ssDNA/RNA viruses in gen-
eral and HBV in particular, there might be a direct correla-
tion between the net charge of flexible tails of capsid core
proteins and the size of a packaged genome (7–9). For
many ssRNA/ssDNAviruses, the genome packaging is con-
trolled by the flexible peptide arms of the capsid proteins,
and the genome size is determined by a fixed charge ratio
between those macromolecules (22). While a positive cor-
relation between the genome size and capsid charge has
been widely recognized, a theoretical investigation from
2011 suggests that different charge ratios are possible for
the interaction between nucleic acids and capsid proteins
(27).
Fig. 3 presents the packaged RNA size (NRNA) as a func-
tion of the net charge of CTD tails (Qtail) of the HBV core
proteins. Both the theoretical results and experiment data
for the optimal genome size (shown in Fig. 2) are referred
to Qtail for WT and mutants. Although there is an overall
trend that NRNA increases with Qtail, neither experimental
data nor theoretical predictions yield a fixed charge ratio be-
tween RNA and CTD tails (NRNA/Qtail). For example, two
mutants have same Qtail but noticeably different NRNA
values (e.g., 167 and 169).
A number of thermodynamic models have been proposed
to explain the optimal charge ratio between nucleic acids
and capsid proteins. For example, Hu et al. (23) argued
that the optimal RNA size is dependent on the contour
length of peptide tails, and obtained a fixed charge ratio
of N/Q ¼ 2. Different charge ratios (<1, 1, and 2) have
also been predicted with the assumption of a uniform capsid
1.2 1.6 2.0 2.4 2.8 3.2
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FIGURE 3 Correlation between the packaged RNA size (NRNA) and the
net charge of C-terminal tails (Qtail). (Solid line) N/Q ¼ 1.61 was proposed
by Belyi and Muthukumar (22). To see this figure in color, go online.
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Most notably, Belyi and Muthukumar (22) determined
N/Q ~ 1.6 based on the counterion-condensation theory
for RNA and peptide tails. The linear charge relation is
compared in Fig. 3 together with our model and experi-
mental data. Clearly, neither theWT nor mutant HBV nucle-
ocapsids follow the universal charge ratio. Instead, the DFT
calculations show that the charge ratio varies from 1.1 to 1.8
depending on specific mutants. A 2012 experiment also re-
vealed the lack of a universality for the charge ratio on RNA
packaging in brome mosaic virus (26). It was found that the
number of charges in capsid protein arms is not a sole factor
in controlling the RNA packaging. Our DFT calculations on
HBV packaging draw a similar conclusion that the addi-
tional controlling factors beyond the net charge effect
should be considered. As indicated before (34), the excluded
volume and correlation effects of macromolecules and salt
ions contribute to the RNA packaging process. A proper
consideration of such effects allows us to quantify the equi-
librium thermodynamics and obtain the optimal size of the
packaged genome.
In obtaining the results shown in Fig. 3, we assumed that
three serine residues (155, 162, and 170th aa) are phosphor-
ylated for the WT virus and each phosphorylated serine
carries a negative charge. Although those positions are
most relevant to serine phosphorylation in vivo, it has
been reported that serine residues at 176 and 178th aa are
also possibly phosphorylated (54). If that is the case, we
find the optimal genome size would be reduced by ~170
bases in comparison to that for the WT virus with only
three sites of serine phosphorylation. When all five serine
sites are phosphorylated, the RNA size is longer (by ~70
bases) than that of the C-terminal truncated mutant 169
with regular phosphorylation, although these mutants have
the same net charge (Qtail) on the CTD tails. Such a differ-
ence is not accounted for by the universal charge ratio or
charge-balance hypothesis, but somewhat expected because,
as discussed below, the additional phosphorylation sitesare located around the C-terminal end region and mostly
exposed at the capsid surface.Nucleocapsid stability
Earlier experimental work suggests that encapsidation of
pgRNA stabilizes HBV nucleocapsids in comparison to
empty capsids (51). In addition, the nucleocapsid stability
changes during the reverse transcription from RNA to
DNA, indicating its potential correlation with viral matura-
tion (55). Moreover, mutagenesis experiments reveal that
partial truncation of CTD influences the RNA packaging
and DNA synthesis. For example, Le Pogam et al. (7) found
that HBV mutants with a truncation of no more than 10 of
C-termini (e.g., 173 CP residues) were able to produce a
comparable amount of DNA as WT, while further deletion
of CTD residues critically impeded the DNA production.
Nucleocapsids of those mutants (i.e., >10 residues are trun-
cated from CTD) maintain a reduced stability, and their
packaged genome is easily digested by a cellular nuclease.
The stability of HBV nucleocapsids depends on the
free energy of complex formation between the RNA/DNA
genome and oppositely charged capsid proteins. Approxi-
mately, the free energy can be divided into contributions
from capsid formation from the protein subunits (Fem) and
that due to the interaction of nucleic acids with the flexible
domains of the capsid proteins (Fplex) (56):
FNC ¼ Fem þ Fplex: (10)
In Eq. 10, the first term on the right side represents the
reversible work to transfer diluted core protein subunits to
the assembled empty capsid, and the other is the complexa-
tion energy of RNA/DNA genome and CTD segments. The
complex formation energy is determined from the free en-
ergy differences among the confined macromolecules, the
isolated genome, and CTDs chains at infinite dilution. Pre-
viously, we proposed an approximate complexation free en-
ergy to account for the changes in the chain elastic energy,
the molecular excluded volume effects, the electrostatic in-
teractions among macromolecules and small ions, and the
entropy of mixing (56). Among various HBV mutants, the
free energy of empty capsid is same for all cases, and thus
we only compare the free energy of chain complexation
(Fplex) for mutants with different lengths of the CTD tail.
Fig. 4 shows the complex formation free energy versus
the CTD chain length for those HBV mutations considered
above. Here a negative value means that encapsidation of
macromolecules is energetically favorable, i.e., stabilizes
the nucleocapsid. As expected, Fplex is negative for WT nu-
cleocapsids (CP183) and for mutants with a small-degree
truncation (CP179 and CP173). In other words, the corre-
sponding nucleocapsids are more stable than the empty
capsid. However, the complexation free energy is positive
for those with a large degree of CTD truncation. We noteBiophysical Journal 109(8) 1689–1697
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FIGURE 4 The free energy of RNA encapsidation depends on the CTD
length. The complexation free energy (Fplex) of RNA and CTD chains is
determined for WT and mutants. (Sigmoidal line) Guide to the eye.
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FIGURE 5 (A–E) Radial distributions of RNA (blue solid line) and CTD
chains (red dashed line) in WT and mutant HBV nucleocapsids (57). (r)
Radial distance from the capsid center; (perpendicular dashed lines) posi-
tion of the capsid shell. (F) The average number of amino-acid (aa) residues
from the CTD tails located outside the capsid wall for WT and mutants. To
see this figure in color, go online.
1694 Kim and Wua sigmoidal change of the complexation energy with regard
to the size of CTD tails as shown by the solid line in Fig. 4.
The transition occurs at approximately CP173 to CP171,
where Fplex changes from a negative to a positive value.
As mentioned before, earlier experiments indicate that
nucleocapsids with a truncation up to 10 C-termini residues
(CP173) are relatively stable. We may rationalize such a sta-
bility variation according to our coarse-grained model. Our
theoretical results indicate that encapsidation of RNA-CTD
chains entails a greater amount of unfavorable positive free
energy for higher-order truncations than for the case of
CP173 (e.g., CP171). Accordingly, the population of those
mutants with unfavorable RNA encapsidation should be
relatively small, and the resultant DNA synthesis should
be substantially constrained.Structure of HBV nucleocapsids
Whereas cryo-EM images are available for both WT and
mutant HBV nucleocapsids (34), the molecular structures
for the flexible components of the virus remain poorly un-
derstood. With CTD tails fully confined inside the capsid,
our previous DFT calculation predicted a thin layer of
RNA chain and a brushlike distribution of the CTD seg-
ments. Here we conduct similar structural analyses by ex-
panding the computation range from inside the capsid to
the outside area. In addition, more detailed capsid features
are implemented such that CTD segments are set to be ex-
posable into the outside region. It has been shown that
such semipermeable characters are relevant to build the
HBV capsid model (36).
Fig. 5 presents the radial distributions of RNA and CTD
segments at different levels of CTD truncation. Here the
RNA content is selected from the optimal genome size calcu-
lated from DFT. As indicated in a previous report (34), RNA
segments exhibit extremely high contact density at the inner
capsid surface. Immediately following the RNA layer are
tethered CTD segments, with the rest forming a brushlikeBiophysical Journal 109(8) 1689–1697structure. For mutants with truncation over five residues,
we find the radial distributions of capsid components are
virtually identical to our previous predictions from a confined
capsid model (34). Noticeably, however, some CTD seg-
ments approach outside the capsid region for both WT and
the CP179 mutant. Fig. 5, right side, compares the average
number of exposed CTD residues for different mutants. For
WT nucleocapsids, 3–4 CTD residues per capsid protein
are exposed in the outside region. Because these residues
do not participate in the complex formation with encapsi-
dated RNA,we expect ~10% of CTD segments are not essen-
tial for the genome packaging. The exposure of CTD tails in
WTHBV virus is consistent with previous biochemical anal-
ysis showing their accessibility to proteases and antibodies
(58,59) and recent cryo-electron microscopy structures
(31,60). Because our theoretical calculations assume a spher-
ical symmetry for CTD distributions, we are not able to
distinguish different holes of the capsid shell responsible
for the CTD exposure.
Our theoretical results for the multiregional distributions
of CTD segments inside and outside the capsid may help
to explain how the CTD tails fulfill multiple roles in the
HBV lifecycle. As discussed above, CTDs are indispensable
for genome encapsidation and replication. Other roles
Electrostatics of Viral Replication 1695have also been identified, such as mediating the nuclear
localization and maturation signal (30–33,61–63). Specif-
ically, it has been noted that the arginine-rich domains of
each CTD tail play a critical role in interaction with the
capsid exterior, mediating nuclear import and export signals
(32,33,63). The location of CTD tails could regulate the
posttranslational process. Our model suggests that the WT
HBV capsids are optimized to fulfill pgRNA packaging
while maintaining a portion of exposed CTD segments to
conduct a potent signaling role. Mutant CP179 has <2 res-
idues per CTD tail exposed, and such exposure is not
observed for mutants with shorter CTDs. Consequently,
those mutants may lose the capability to deliver the matura-
tion signal.CONCLUSIONS
We have investigated the thermodynamics of HBV nucleo-
capsid formation based on a coarse-grained molecular
model for the key viral components and the intracellular
electrolyte solution. The genome contents in stable nucleo-
capsids are determined following an equilibrium criterion
that minimizes the thermodynamic potential for RNA
encapsidation. The theoretical results are found in good
agreement with existing experiments on the nucleocapsid
formation for both WT and mutant HBV capsids with trun-
cated C-termini of the core proteins. The thermodynamic
model confirms that pgRNA encapsidation is mainly domi-
nated by nonspecific electrostatic and excluded-volume in-
teractions among oppositely charged macromolecules. In
contrast to previous investigations, both experimental and
theoretical results indicate that the RNA content is not line-
arly correlated with the net charge of the CTD tails.
This model is an extension of our previous work on elec-
trostatic regulation of HBV replication. One key difference
is that this model allows for the partial exposure of CTD
tails outside the capsid surface, while the earlier work as-
sumes a full confinement of CTD tails (34). The exposure
of the CTD tails had been speculated upon for decades,
but only recently confirmed by experimental and theoretical
studies. We find that only ~10% of CTD segments are
distributed outside the capsid in the WT HBV virus, and
the CTD extension is insignificant for most mutants with
truncated CTD tails. In a WT capsid, the majority of CTD
segments are located near the RNA segments around the in-
ner capsid shell, while 3–4 residues from each CTD tail are
exposed outside the HBV capsid. To a certain degree, this
work provides a support of the capsid confinement effect hy-
pothesized in our earlier work. Indeed, the optimal size of
packaged RNA predicted from this work is similar to that
from our previous model.
In addition to RNA-capsid charge correlations, this
work examines phosphorylation effects and capsid stability.
Furthermore, we have investigated the spatial distributions
of RNA and CTD segments in both WT and mutant capsidsand how the location of CTD tails is optimized to fulfill the
multiple roles in assembly, maturation, and envelopment of
HBV capsids. The thermodynamic stability of a nucleo-
capsid is affected not only by the overall charge balance be-
tween oppositely charged macromolecules, but also by the
molecular excluded volume effects and the charge distribu-
tion within the CTD tails. The RNA encapsidation free en-
ergy indicates that nucleocapsids with shortened C-termini
are less stable in comparison to the WT capsid. The reduc-
tion in stability explains why mutants with higher degrees of
truncation become easily degradable and fail to maintain its
capability for DNA synthesis. These theoretical predictions
help us to better understand the molecular details of the
HBV replication cycle and develop more effective antiviral
strategies.SUPPORTING MATERIAL
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